On 4 March 2026, Suzhou Basecare Medical Corporation Limited (BASECARE-B, stock code 02170) published its monthly return for the period ended 28 February 2026. Total authorized/registered share capital stood at 273.53 million RMB, consisting of 82.71 million H shares, 183.18 million domestic shares, and 7.63 million unlisted foreign shares. There were no increases or decreases in any share classes during the month.

According to the return, no share repurchases, share redemptions, or issues under options, warrants, or convertible instruments were recorded. The company also confirmed that it met the required public float threshold for H shares in the reported period.